Company intelligence / Profile preview
CellBion
Seoul, Seoul, South Koreacellbion.co.kr ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
CellBion is a South Korean biotech company specializing in the development of radiopharmaceutical agents for both diagnosis and treatment, with a focus on oncology. Its lead candidate, Lu‑177‑DGUL, targets PSMA in metastatic castration-resistant prostate cancer and is currently in Phase 2 clinical trials. The agent has demonstrated high tumor uptake and low kidney accumulation compared to competitors. The pipeline also includes diagnostic agents for cardiovascular disease and solid tumors as well as antibody-radionuclide conjugates in preclinical stages.
- Therapeutic areas
- OncologyCardiovascular
- Modalities
- Therapeutic radiopharmaceuticalsDiagnostic radiopharmaceuticalsPeptide conjugate radionuclideAntibody-radionuclide conjugate
- Industry
- Biotech
02
Drug pipeline
4 assets3 more assets in the full pipeline.
Request access →03
Partnerships
Centre for Probe Development and Commercialization ("CPDC") – CDMO partner for development/manufacturing/supply of Lu–177–DGUL for clinical trials in South Korea with plans to expand into North America
Beyond the preview
Go deeper on CellBion.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on CellBion.